About the Journal
The IJHDR was created in 2008, under the coordination of Prof. Carlos Zacharias (UNESP, Brazil) and Prof. Silvia Waisse (PUC, Brazil) to offer high-level scientific information about experimental and clinical studies on homeopathy and technology of high dilutions. It was formerly hosted on UNESP - Guaratinguetá (Brazil) server and, since 2015 it is hosted in its own domain (highdilutions.org). Prof. Carlos Zacharias, Prof. Saurav Arora (India), and Prof. Maria Olga Kokornaczik (Switzerland) were the former Editors-in-chief. Since 2019, the journal is under the coordination of an Editorial team composed of Prof. Leoni V Bonamin (UNIP, Brazil), Prof. Adalberto Von Ancken (HD-Science, Brazil), and Prof. Francisco Eizayaga (Univ. Maimonides, Argentina).
This is an open-access peer-reviewed Journal about high-quality research on high dilutions and homeopathy, and a communication channel about the GIRI ("Groupe International de Recherche Sur l´infinitésimal" - https://giri-society.org/) activities. Only original papers are accepted.
The journal is supported by HRI (https://www.hri-research.org/), HD Science (https://www.hdscience.com.br/), and ECH (https://homeopathyeurope.org/).
From 2008 to 2021, the issues were published quarterly; from June 2022, the annual periodicity has changed to a continuous flow system.
Clinical Trials, experimental and field research, and systematic reviews are welcome. Although it is an open-access journal, there is no submission fee since all staff works on a volunteering basis.
Since August 2021, IJHDR adopts the Creative-Commons license:
Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
The journal preserves the authors` copyright, with the condition that the first publication made in IJHDR is mentioned in any further publication of the same text.
Excellence in scientific methodology is required and the authors keep all responsibility on the references they cite in each paper. Papers previously published in "pre-print" platforms are welcome since it is mentioned as a subtitle.
For more information, see the "SUBMISSION" page.